TABLE 1.
Patient and tumor characteristics
| N = 152 (%) | |
|---|---|
| Age | |
| <40 | 6 (3.9%) |
| 40–59 | 57 (37.5%) |
| 60–79 | 84 (55.3%) |
| >80 | 5 (3.3%) |
| Self‐identified race | |
| White | 124 (87.3%) |
| Non‐white | 18 (12.7%) |
| Other or Unknown | 10 (6.6%) |
| Sex | |
| Male | 124 (87.3%) |
| Female | 28 (18.4%) |
| Smoking status | |
| Current | 17 (11.2%) |
| Former | 66 (43.4%) |
| Never | 69 (45.4%) |
| Pack year history | |
| >10 PYH | 66 (43.4%) |
| <10 PYH | 85 (56.3%) |
| Unknown PYH | 1 (0.7%) |
| Site | |
| Oral cavity | 37 (24.3%) |
| Oropharynx | 60 (39.5%) |
| Nasopharynx | 11 (7.2%) |
| Hypopharynx | 7 (4.6%) |
| Larynx | 10 (6.6%) |
| Salivary gland | 1 (0.7%) |
| Nasal cavity | 6 (3.9%) |
| External auditory canal | 3 (2.0%) |
| Cutaneous SCC | 6 (3.9%) |
| Primary site unknown or not documented | 11 (7.2%) |
| Viral association | |
| Yes | 61 (40.7%) |
| No | 89 (59.3%) |
| Unknown | 2 (1.4%) |
| Virus type | |
| HPV+ | 54 (35.5%) |
| EBV+ | 7 (4.6%) |
| PD‐L1 expression testing | |
| Yes—>1% | 9 (5.9%) |
| Yes—<1% | 1 (0.7%) |
| No | 142 (93.4%) |
| ECOG | |
| 0 | 42 (28.8%) |
| 1 | 75 (51.4%) |
| 2 | 27 (18.5%) |
| 3 | 2 (1.4%) |
| Unknown | 6 (3.9%) |